Ownership history in Alphabet Inc. · 14 quarters on record
This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Sana Biotechnology Inc. (SANA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 2,812,500 | — | 0% | 0.44% | $11.4M | $4.07 |
| 2025 Q3 | UNCHANGED | 2,812,500 | — | 0% | 0.41% | $10.0M | $3.55 |
| 2025 Q2 | UNCHANGED | 2,812,500 | — | 0% | 0.36% | $7.7M | $2.73 |
| 2025 Q1 | UNCHANGED | 2,812,500 | — | 0% | 0.30% | $4.7M | $1.68 |
| 2024 Q4 | UNCHANGED | 2,812,500 | — | 0% | 0.27% | $4.6M | $1.63 |
| 2024 Q3 | UNCHANGED | 2,812,500 | — | 0% | 0.64% | $11.7M | $4.16 |
| 2024 Q2 | UNCHANGED | 2,812,500 | — | 0% | 0.78% | $15.4M | $5.46 |
| 2024 Q1 | UNCHANGED | 2,812,500 | — | 0% | 1.12% | $28.1M | $10.00 |
| 2023 Q4 | UNCHANGED | 2,812,500 | — | 0% | 0.53% | $11.5M | $4.08 |
| 2023 Q3 | UNCHANGED | 2,812,500 | — | 0% | 0.70% | $10.9M | $3.87 |
As of 2025 Q4 — sorted by position size